Trends and Outcomes of TAVR: An Analysis Using the National Inpatient Sample and Readmissions Database.

IF 2.9 Q2 MEDICINE, RESEARCH & EXPERIMENTAL
Vivek Joseph Varughese, Vignesh Krishnan Nagesh, Hadrian Hoang-Vu Tran, Olivia Yessin, Harsh Jha, Ashley Mason, Audrey Thu, Simcha Weissman, Adam Atoot
{"title":"Trends and Outcomes of TAVR: An Analysis Using the National Inpatient Sample and Readmissions Database.","authors":"Vivek Joseph Varughese, Vignesh Krishnan Nagesh, Hadrian Hoang-Vu Tran, Olivia Yessin, Harsh Jha, Ashley Mason, Audrey Thu, Simcha Weissman, Adam Atoot","doi":"10.3390/diseases13050149","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background</b>: Transcatheter aortic valve replacement (TAVR) has become the preferred treatment for severe aortic stenosis in high- and intermediate-risk patients, with expanding indications for lower-risk populations. However, post-procedural complications, such as stroke, conduction disturbances, and heart failure readmissions, remain concerns. The aim of our study is to analyze the national trends in TAVR procedures, in-hospital outcomes, major readmission causes, and the association of risk factors for readmissions following TAVR. <b>Methods</b>: We analyzed NIS data (2018-2022) to assess TAVR utilization trends, patient demographics, and in-hospital outcomes. The NRD (2021-2022) was used to evaluate 60-day readmission rates for stroke, complete heart block, and heart failure. Multivariate regression models were employed to identify risk factors having significant association with major readmission causes. <b>Results</b>: TAVR utilization increased from 10,788 cases in 2018 to 17,784 in 2022, with a concurrent decrease in in-hospital mortality (1.33% to 0.90%) and length of stay (3.88 to 2.97 days). Of 123,376 TAVR index admissions in 2021, 28,654 patients had 66,100 readmission events (53.57%) in the 60 days following discharge. Heart failure (17,566 cases, 26.57% of readmissions) was the most common readmission cause, followed by complete heart block (1760 cases, 2.66% of readmissions) and stroke (284 cases, 0.42% of readmissions). Predictors of post-TAVR stroke included uncontrolled hypertension (OR 2.29, <i>p</i> < 0.001) and chronic heart failure (OR 2.73, <i>p</i> < 0.001). Left bundle branch block (LBBB) was strongly associated with complete heart block (OR 12.89, <i>p</i> < 0.001) and heart failure readmissions (OR 7.65, <i>p</i> < 0.001). <b>Conclusions</b>: TAVR utilization has increased with improving perioperative outcomes, but post-TAVR readmissions remain significant, particularly for heart failure, stroke, and conduction disturbances. Pre-procedural uncontrolled hypertension, hyperlipidemia, congestive heart failure, and atrial fibrillation were risk factors with significant association with stroke in the 60 days following TAVR. The presence of documented pre-procedural LBB, RBB, as well as BFB were risk factors with significant association with complete heart block following TAVR placements. Pre-procedural LBB, RBB, BFB, and atrial fibrillation were risk factors having significant association with heart failure readmissions in the 60 days following TAVR.</p>","PeriodicalId":72832,"journal":{"name":"Diseases (Basel, Switzerland)","volume":"13 5","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12110121/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diseases (Basel, Switzerland)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/diseases13050149","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Transcatheter aortic valve replacement (TAVR) has become the preferred treatment for severe aortic stenosis in high- and intermediate-risk patients, with expanding indications for lower-risk populations. However, post-procedural complications, such as stroke, conduction disturbances, and heart failure readmissions, remain concerns. The aim of our study is to analyze the national trends in TAVR procedures, in-hospital outcomes, major readmission causes, and the association of risk factors for readmissions following TAVR. Methods: We analyzed NIS data (2018-2022) to assess TAVR utilization trends, patient demographics, and in-hospital outcomes. The NRD (2021-2022) was used to evaluate 60-day readmission rates for stroke, complete heart block, and heart failure. Multivariate regression models were employed to identify risk factors having significant association with major readmission causes. Results: TAVR utilization increased from 10,788 cases in 2018 to 17,784 in 2022, with a concurrent decrease in in-hospital mortality (1.33% to 0.90%) and length of stay (3.88 to 2.97 days). Of 123,376 TAVR index admissions in 2021, 28,654 patients had 66,100 readmission events (53.57%) in the 60 days following discharge. Heart failure (17,566 cases, 26.57% of readmissions) was the most common readmission cause, followed by complete heart block (1760 cases, 2.66% of readmissions) and stroke (284 cases, 0.42% of readmissions). Predictors of post-TAVR stroke included uncontrolled hypertension (OR 2.29, p < 0.001) and chronic heart failure (OR 2.73, p < 0.001). Left bundle branch block (LBBB) was strongly associated with complete heart block (OR 12.89, p < 0.001) and heart failure readmissions (OR 7.65, p < 0.001). Conclusions: TAVR utilization has increased with improving perioperative outcomes, but post-TAVR readmissions remain significant, particularly for heart failure, stroke, and conduction disturbances. Pre-procedural uncontrolled hypertension, hyperlipidemia, congestive heart failure, and atrial fibrillation were risk factors with significant association with stroke in the 60 days following TAVR. The presence of documented pre-procedural LBB, RBB, as well as BFB were risk factors with significant association with complete heart block following TAVR placements. Pre-procedural LBB, RBB, BFB, and atrial fibrillation were risk factors having significant association with heart failure readmissions in the 60 days following TAVR.

TAVR的趋势和结果:使用国家住院患者样本和再入院数据库的分析。
背景:经导管主动脉瓣置换术(TAVR)已成为重度主动脉瓣狭窄高、中危患者的首选治疗方法,适应症在低危人群中逐渐扩大。然而,手术后并发症,如中风、传导障碍和心力衰竭再入院,仍然值得关注。本研究的目的是分析全国TAVR手术的趋势、住院结果、主要再入院原因以及TAVR后再入院的危险因素的相关性。方法:我们分析了NIS数据(2018-2022),以评估TAVR的使用趋势、患者人口统计学和住院结果。NRD(2021-2022)用于评估中风、完全性心脏传导阻滞和心力衰竭的60天再入院率。采用多元回归模型确定与主要再入院原因有显著关联的危险因素。结果:TAVR使用率从2018年的10788例增加到2022年的17784例,住院死亡率从1.33%降至0.90%,住院时间从3.88天降至2.97天。在2021年入院的123376例TAVR指数患者中,28654例患者在出院后60天内再入院66100例(53.57%)。心衰(17566例,再入院率26.57%)是最常见的再入院原因,其次是完全性心脏传导阻滞(1760例,再入院率2.66%)和脑卒中(284例,再入院率0.42%)。tavr后卒中的预测因子包括未控制的高血压(OR 2.29, p < 0.001)和慢性心力衰竭(OR 2.73, p < 0.001)。左束支传导阻滞(LBBB)与完全性心脏传导阻滞(OR 12.89, p < 0.001)和心力衰竭再入院(OR 7.65, p < 0.001)密切相关。结论:TAVR的使用随着围手术期预后的改善而增加,但TAVR后再入院仍然很重要,特别是心力衰竭、中风和传导障碍。术前未控制的高血压、高脂血症、充血性心力衰竭和心房颤动是TAVR术后60天内发生卒中的危险因素。术前记录的LBB、RBB和BFB是与TAVR放置后完全心脏传导阻滞显著相关的危险因素。术前LBB、RBB、BFB和心房颤动是与TAVR后60天心力衰竭再入院有显著关联的危险因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.80
自引率
0.00%
发文量
0
审稿时长
6 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信